HCPCS Level IIdrugActive
J9185
Fludarabine phosphate inj
BETOS: O1D
Effective: 2023-01-01
Description
Injection, fludarabine phosphate, 50 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Fludarabine Phosphate
Manufacturer
Hikma Pharmaceuticals USA Inc.
HCPCS Dosage
50 MG
Billing Units
1.0000
5
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.